Carolyn Miller

Sep 3, 2024 | mdpi.com | Maickel Armenteros |Laura Weber |Carolyn Miller |Manon Denux

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

May 18, 2023 | einpresswire.com | Carolyn Miller

AB-2004 adsorbs certain substances produced by bacteria in the gut to reduce their ability to enter the bloodstream and reach the brain. Clinical Study Provides Preliminary Evidence for a Reduction in Irritability With Requiring a Change in DietWe strongly believe that AB-2004 can improve the quality of life of many children with autism and their families.”— A. Stewart Campbell, PhD, Axial Therapeutics CEO and Head of R&D.